摘要
目的:研究活血化瘀中药治疗急性冠状动脉综合征的临床效果。方法:选取我院2013年9月-2014年9月期间收治的56例急性冠状动脉综合征患者,随机分为两组,实验组予活血化瘀中药配合西药进行治疗,对照组予常规的西药治疗,进行为期4周的跟踪治疗分析。根据数据结果进行两组患者的血清s CD40L信息数据对比分析。结果:两组患者的血清s CD40L水平均有所降低,不过实验组疗效更显著,经SPSS18.0系统分析,P<0.05,差异具有统计学意义。结论:活血化瘀中药对冠状动脉综合患者的血清s CD40L水平有着不俗的治疗效果。
Objective: Clinical effects of TCM medicine of the Huoxue Huayu type on ACS were observed. Methods: 56 patients from September 2013 to September 2014 were randomly divided into two groups; the study group was given TCM medicine of the Huoxue Huayu type plus western medicine; the control group received conventional treatment, for 4 weeks. Serum sCD40L data in both groups was comparatively analyzed. Results: Serum sCD40L data in both groups were decreased; and that in the study group was decreased obviously, P〈0.05. Conclusion: TCM medicine of the Huoxue Huayu type was signiifcantly effective on ACS.
出处
《中医临床研究》
2016年第17期94-94,96,共2页
Clinical Journal Of Chinese Medicine